Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib
暂无分享，去创建一个
P. Bruzzi | A. Ardizzoni | M. Tiseo | B. Bortesi | P. Petronini | R. Alfieri | C. Caffarra | C. Fumarola | A. Cavazzoni | R. Bordonaro | M. Bartolotti | H. S. Soto Parra | L. Ruffini | P. Spadaro | M. Scarlattei | M. Ippolito | S. Cosentino | F. Latteri